查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726234

外用药物契约製造市场规模、份额、趋势分析报告：按产品类型、业务规模、最终用途、地区和细分市场预测，2025 年至 2030 年

Topical Drugs Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type, By Scale Of Operation, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

外用药物契约製造市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，预计到 2030 年全球外用药物契约製造市场规模将达到 545.5 亿美元。

预计 2025 年至 2030 年间，市场复合年增长率将达到 11.05%。目前，受不断变化的治疗需求、外包趋势和技术进步的推动，全球外用药物契约製造市场正在经历显着增长。此外，皮肤病患病率的不断上升、老年人口的不断增长，再加上人们对乳膏、凝胶、软膏、喷雾剂和经皮吸收贴片非侵入性给药方式的偏好，使得受託製造厂商（CMO）等外包服务对于优化成本、确保法规遵从性和提高生产能力至关重要。此外，CMO 还提供许多好处，有助于简化业务、降低内部製造成本并加快产品上市时间，从而进一步促进市场扩张。此外，消费者对外用药物的需求不断增长，使得外包成为一项策略重点，特别是对于需要专业知识和适应性基础设施的半固态和经皮製剂等产品线。

此外，成本动态在市场成长中发挥关键作用。根据定价分析，北美提供符合监管标准的高品质製造，而印度、中国和韩国等亚太国家则提供更具成本效益的製造选择和不断提高的产能。劳动力成本下降、政府支持政策以及符合良好生产规范 (GMP) 的市场的发展等因素正在推动亚太市场的发展。此外，连续製造、奈米胶囊化、先进均质化和 3D 列印等技术创新正在提高配方精度、生物有效性和批次一致性。这些进步正在帮助 CMO 应对复杂的产品需求并满足消费者对功效和客製化日益增长的期望。

此外，定价模型正在透过将业务绩效与财务结果相结合而不断发展。然而，美国对进口活性药物成分（API）和辅料征收关税等外部因素正在给供应链带来成本压力，尤其影响到出口商。儘管存在这些挑战，但预计市场在预测期内仍将成长。同样，策略倡议和加速产品发布正在推动市场发展。例如，2024年7月，Arcutis BIoTherapeutics, Inc.宣布在美国推出ZORYVE Cream 0.15%，用于治疗成人和6岁以下儿童的轻度至中度异位性皮肤炎。这种新型药膏每天使用一次，不含类固醇，可快速缓解疼痛、减少搔痒，进而达到长期控制。预计此类技术创新将在预测期内进一步推动市场发展。

外用药物契约製造市场报告重点

  • 半固态剂型占市场主导地位，2024 年的份额为 65.54%。推动这一增长的因素包括皮肤病患病率的上升、患者对标靶治疗的偏好、半固态剂型的便利性，以及治疗和化妆品领域对改善药物吸收、稳定性和美观性的需求。
  • 根据业务规模，商业部门在 2024 年占据了最大的市场占有率。这些因素包括外包趋势的上升、对皮肤病学和经皮治疗的需求的增加、监管要求、成本效益以及需要专业製造技术的日益复杂的配方。
  • 到 2024 年，製药公司将占据最终用途最高的市场占有率。由于对非侵入性治疗、慢性皮肤病治疗、提高患者依从性的需求不断增加，以及美容皮肤科和先进的经皮给药系统机会不断增加，这些公司正在利用 CMO 服务。
  • 由于美国、加拿大等地受託製造厂商(CMO) 数量的增加，预计北美在预测期内的复合年增长率将达到 10.37%。此外，熟练劳动力的可用性和监管环境预计将显着促进该地区市场的扩张。

目录

第一章调查方法与范围

第二章执行摘要

第三章外用药物契约製造市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 定价模式分析
  • 科技
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章：外用药物契约製造市场：依产品类型估算与趋势分析

  • 外用药物契约製造市场（按产品类型）：细分仪表板
  • 外用药物契约製造市场（依产品类型）：波动分析
  • 依产品类型，2018-2030
  • 半固态製剂
    • 奶油
    • 软膏
    • 凝胶
    • 其他的
  • 液体製剂
  • 固态製剂
  • 经皮产品

第五章：外用药物契约製造市场：按业务规模进行的估计和趋势分析

  • 外用药物契约製造市场（按业务规模）：细分仪表板
  • 外用药物契约製造市场（依企业规模）：波动分析
  • 按业务规模，2018-2030年
  • 临床
  • 商业的

第六章：外用药物契约製造市场：依最终用途的估计和趋势分析

  • 局部用药契约製造市场（依最终用途）：细分仪表板
  • 外用药物契约製造市场（依最终用途）：波动分析
  • 依最终用途，2018-2030 年
  • 製药公司
  • 生物製药公司
  • 其他的

第七章：外用药物契约製造市场：按地区估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • MedPharm
    • DPT Laboratories Ltd
    • Cambrex Corporation
    • Kindeva Drug Delivery
    • AbbVie Contract Manufacturing
    • NextPharma
    • Catalent Pharma Solutions
    • Thermo Fisher Scientific
    • Lonza Group
    • The Lubrizol Corporation
    • SGS SA
    • Bora Pharmaceutical CDMO
Product Code: GVR-4-68040-555-9

Topical Drugs Contract Manufacturing Market Growth & Trends:

The global topical drugs contract manufacturing market is expected to reach USD 54.55 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.05% from 2025 to 2030. Currently, the global market for contract manufacturing of topical drugs is currently experiencing significant growth, driven by evolving therapeutic needs, outsourcing trends, and advancements in technology. Moreover, with the increasing prevalence of dermatological conditions, coupled with a rising geriatric population and a preference for non-invasive drug delivery methods such as creams, gels, ointments, sprays, and transdermal patches has made outsourcing services like Contract Manufacturing Organizations (CMOs) essential for optimizing costs, ensuring regulatory compliance, and enhancing production capabilities. In addition, CMOs offer numerous advantages that support streamline operations, lower in-house manufacturing expenses, and speed up product commercialization, further contributing to market expansion. In addition, with the rising consumer demand for topical drugs, outsourcing has become a strategic priority, particularly for semi-solid and transdermal product lines that require specialized expertise and adaptable infrastructure.

Furthermore, cost dynamics play a crucial role in the growth of the market. Based on the pricing analysis, the North America provides high-quality manufacturing that complies with regulatory standards, while the Asia Pacific's countries like India, China, and South Korea offers more cost-effective production options with growing capabilities. Factors such as lower labor costs, supportive government policies, and a developing infrastructure complaint with Good Manufacturing Practices (GMP) are fueling the market in Asia Pacific. Furthermore, technological innovations such as continuous manufacturing, nanoencapsulation, advanced homogenization, and 3D printing are improving formulation accuracy, bioavailability, and batch consistency. These advancements support the CMOs to meet complex product demands and meet rising consumer expectations for efficacy and customization.

Furthermore, pricing models are evolving with aligning financial results with performance. However, external factors like U.S. tariffs on imported active pharmaceutical ingredients (APIs) and excipients have created cost pressures in the supply chain, particularly impacting exporters. Despite these challenges, the market is expected to witness growth during the forecast period. Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in July 2024, Arcutis Biotherapeutics, Inc. announced the release of ZORYVE cream 0.15% for the treatment of mild to moderate atopic dermatitis in both adults and children under 6 in the U.S. This new cream, which is applied once daily and contains no steroids, provides quick relief from symptoms and reduces itching, allowing for better long-term management of the condition. Such innovations are expected to further propel the market during the forecast period.

Topical Drugs Contract Manufacturing Market Report Highlights:

  • The semi-solid formulations segment dominated the market, with a share of 65.54% in 2024. This growth is driven by the increasing prevalence of skin diseases, patient preferences for targeted therapies, the convenience of semi-solid formulations, and the demand for improved drug absorption, stability, and aesthetic appeal within both therapeutic and cosmetic sectors.
  • Based on the scale of operation, the commercial segment held the largest market share in 2024, attributed to the growing trend toward outsourcing, increased demand for dermatological and transdermal therapies, regulatory compliance, increased cost efficiency, and the rising complexity of formulations that require specialized manufacturing expertise.
  • The pharmaceutical companies segment held the largest market share in 2024 based on end-use. These companies leverage CMO services due to increasing demand for non-invasive therapies, treatments for chronic skin conditions, improved patient compliance, and opportunities within cosmetic dermatology and advanced transdermal drug delivery systems.
  • North America is expected to register a growth rate of 10.37% CAGR over the forecast period due to the rising number of contract manufacturing organizations(CMOs) in countries such as the U.S. and Canada. In addition, the availability of a skilled workforce and regulatory scenarios are expected to significantly contribute to the market's expansion in this region.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Scale of Operation
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Topical Drugs Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Topical Drugs Contract Manufacturing Market: Product Type Estimates & Trend Analysis

  • 4.1. Topical Drugs Contract Manufacturing Market, By Product Type: Segment Dashboard
  • 4.2. Topical Drugs Contract Manufacturing Market, By Product Type: Movement Analysis
  • 4.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By Product Type, 2018 - 2030
  • 4.4. Semi-Solid Formulations
    • 4.4.1. Semi-Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Creams
      • 4.4.2.1. Creams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Ointments
      • 4.4.3.1. Ointments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Gel
      • 4.4.4.1. Gel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Liquid Formulations
    • 4.5.1. Liquid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Solid Formulations
    • 4.6.1. Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Transdermal Products
    • 4.7.1. Transdermal Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

  • 5.1. Topical Drugs Contract Manufacturing Market, By Scale of Operation: Segment Dashboard
  • 5.2. Topical Drugs Contract Manufacturing Market, By Scale of Operation: Movement Analysis
  • 5.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By Scale of Operation, 2018 - 2030
  • 5.4. Clinical
    • 5.4.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Commercial
    • 5.5.1. Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Topical Drugs Contract Manufacturing Market, By End Use: Segment Dashboard
  • 6.2. Topical Drugs Contract Manufacturing Market, By End Use: Movement Analysis
  • 6.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Biopharmaceutical Companies
    • 6.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Australia
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. MedPharm
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. DPT Laboratories Ltd
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Cambrex Corporation
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Kindeva Drug Delivery
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. AbbVie Contract Manufacturing
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. NextPharma
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Catalent Pharma Solutions
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Thermo Fisher Scientific
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Lonza Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. The Lubrizol Corporation
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. SGS S.A.
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Bora Pharmaceutical CDMO
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 4 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 5 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 6 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 9 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 10 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 13 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 16 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 19 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 23 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 25 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 26 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 29 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 31 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 32 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 35 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 38 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 41 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 44 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 47 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 54 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 56 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 57 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 59 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 60 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 63 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 66 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 68 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 69 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 73 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 76 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 79 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 86 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 92 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Topical Drugs Contract Manufacturing Market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Topical Drugs Contract Manufacturing Market: Product Type outlook and key takeaways
  • Fig. 20 Topical Drugs Contract Manufacturing Market: Product Type movement analysis
  • Fig. 21 Semi-solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Creams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Ointments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Gel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Transdermal Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Topical Drugs Contract Manufacturing Market: Scale of Operation outlook and key takeaways
  • Fig. 30 Topical Drugs Contract Manufacturing Market: Scale of Operation movement analysis
  • Fig. 31 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Topical Drugs Contract Manufacturing Market: End Use outlook and key takeaways
  • Fig. 34 Topical Drugs Contract Manufacturing Market: End Use movement analysis
  • Fig. 35 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 MEA Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key company categorization
  • Fig. 91 Service heat map analysis
  • Fig. 92 Strategic framework